Tuesday, May 12, 2020

India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...

from NDTV News - Latest https://ift.tt/3bqUqQ1
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Sadhguru Calls Ram Temple Civilisational Milestone, Says Education Reform India's Biggest Challenge

Sadhguru said that every nation needs strong institutions more than strong leaders. from NDTV News Search Records Found 1000 https://ift.t...